Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.699,85
0,32%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Generation Bio Company (GBIO) Generation Bio Company (GBIO) Notizie

GBIO

Generation Bio (GBIO)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:GBIO
DataOraFonteTitoloSimboloCompagnia
13/05/202422:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GBIOGeneration Bio Company
13/05/202422:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GBIOGeneration Bio Company
13/05/202422:05GlobeNewswire Inc.Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial ResultsNASDAQ:GBIOGeneration Bio Company
09/05/202412:59GlobeNewswire Inc.Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual MeetingNASDAQ:GBIOGeneration Bio Company
22/04/202423:31GlobeNewswire Inc.Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual MeetingNASDAQ:GBIOGeneration Bio Company
02/04/202412:59GlobeNewswire Inc.Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:GBIOGeneration Bio Company
06/03/202422:38Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:GBIOGeneration Bio Company
06/03/202422:30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:GBIOGeneration Bio Company
06/03/202422:20GlobeNewswire Inc.Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:GBIOGeneration Bio Company
27/02/202412:59GlobeNewswire Inc.Generation Bio to Present at the 2024 TD Cowen Health Care ConferenceNASDAQ:GBIOGeneration Bio Company
31/01/202422:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
03/01/202422:05GlobeNewswire Inc.Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:GBIOGeneration Bio Company
29/11/202320:25AllPennyStocks.comBiotech Soars After Strategic Reorganization AnnouncementNASDAQ:GBIOGeneration Bio Company
29/11/202312:59GlobeNewswire Inc.Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA PlatformsNASDAQ:GBIOGeneration Bio Company
09/11/202322:15GlobeNewswire Inc.Generation Bio Reports Business Highlights and Third Quarter 2023 Financial ResultsNASDAQ:GBIOGeneration Bio Company
26/10/202312:59GlobeNewswire Inc.Generation Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP PlatformNASDAQ:GBIOGeneration Bio Company
18/10/202312:59GlobeNewswire Inc.Generation Bio Announces Breakthrough in its Non-Viral Genetic Medicine Platform with Novel “Immune-Quiet” DNANASDAQ:GBIOGeneration Bio Company
19/09/202313:30GlobeNewswire Inc.Generation Bio to Present at the Jefferies Cell & Genetic Medicine SummitNASDAQ:GBIOGeneration Bio Company
03/08/202313:30GlobeNewswire Inc.Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference NASDAQ:GBIOGeneration Bio Company
02/08/202322:15GlobeNewswire Inc.Generation Bio Reports Second Quarter 2023 Financial ResultsNASDAQ:GBIOGeneration Bio Company
12/06/202322:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBIOGeneration Bio Company
31/05/202313:30GlobeNewswire Inc.Generation Bio to Present at the 2023 Jefferies Healthcare ConferenceNASDAQ:GBIOGeneration Bio Company
10/05/202322:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GBIOGeneration Bio Company
10/05/202322:15GlobeNewswire Inc.Generation Bio Reports Business Highlights and First Quarter 2023 Financial ResultsNASDAQ:GBIOGeneration Bio Company
09/05/202322:15GlobeNewswire Inc.Generation Bio to Present at the JMP Securities Life Sciences ConferenceNASDAQ:GBIOGeneration Bio Company
26/04/202322:21Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:GBIOGeneration Bio Company
26/04/202322:16Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:GBIOGeneration Bio Company
26/04/202322:11Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:GBIOGeneration Bio Company
11/04/202313:30GlobeNewswire Inc.Generation Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference NASDAQ:GBIOGeneration Bio Company
10/04/202322:45Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:GBIOGeneration Bio Company
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:GBIO

La tua Cronologia

USOTC
SAHRF
Capitan Investment (PK)
LSE
3SIL
Wt Silver 3x
LSE
BQ11
Natixis St.29
BIT
UB03TS
UniCredit Bank
BIT
P1L0P6
BNP Paribas Issuance
LSE
TMI
Taylor Maritime Investme...
COIN
SIBGBP
SIBCoin
LSE
46OP
Perm Mast 58
NASDAQ
AAWSGXX
Citibank Na Point to Poi...
BIT
UC65MC
Unicredit Bank
BIT
UB4QAD
Unicredit Bank
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network